anti-inflammatory peptide (The Hebrew University of Jerusalem)

N/A

Report date: 2025/03/17 20:00:36

Base Information

Drug Nameanti-inflammatory peptide (The Hebrew University of Jerusalem)
Drug Alias NameRA1 peptide (The Hebrew University of Jerusalem)peptides (The Hebrew University of Jerusalem)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionCD44 antigen modulators
TargetsCD44 antigen
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A